Back
MicroSectors Gold Miners 3X Leveraged ETN Vs. Novo Nordisk AS Industry Stock Comparison
Sell
32
GDXU
MicroSectors Gold Miners 3X Leveraged ETN
Last Price:
$30.67
Seasonality Move:
10.89%
Sell
11
NONOF
Novo Nordisk AS
Last Price:
$87.12
Seasonality Move:
8.64%
Sell
32
MicroSectors Gold Miners 3X Leveraged ETN (GDXU)
is a Sell
Is MicroSectors Gold Miners 3X Leveraged ETN a Buy, Sell or Hold?
-
The current MicroSectors Gold Miners 3X Leveraged ETN [GDXU] share price is $30.64. The Score for GDXU is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
GDXU is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $87.12. The Score for NONOF is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
GDXU Stock Price Chart
What is MicroSectors Gold Miners 3X Leveraged ETN's stock price today?
-
The MicroSectors Gold Miners 3X Leveraged ETN share price today is $30.64Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDXU is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight selling pressure.
GDXU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.06 | Sell |
Relative Strength Index (14 RSI): | 44.38 | Sell |
Chaikin Money Flow: | 755520 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.09 - 37.87) | Sell |
Bollinger Bands (100): | (34.34 - 50.46) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.17 | Sell |
Relative Strength Index (14 RSI): | 32.19 | Sell |
Chaikin Money Flow: | -1350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (91.04 - 111.82) | Sell |
Bollinger Bands (100): | (102.11 - 130.43) | Sell |
GDXU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.2 | Buy |
20-day SMA: | 32.83 | Sell |
50-day SMA: | 39.28 | Sell |
200-day SMA: | 39.87 | Sell |
8-day EMA: | 29.14 | Buy |
20-day EMA: | 31.86 | Sell |
50-day EMA: | 36.7 | Sell |
200-day EMA: | 39.03 | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.63 | Buy |
20-day SMA: | 99.79 | Sell |
50-day SMA: | 104.86 | Sell |
200-day SMA: | 124.53 | Sell |
8-day EMA: | 89.41 | Sell |
20-day EMA: | 96.18 | Sell |
50-day EMA: | 104.4 | Sell |
200-day EMA: | 115.91 | Sell |
MicroSectors Gold Miners 3X Leveraged ETN Earnings Growth & GDXU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
MicroSectors Gold Miners 3X Leveraged ETN Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |